Replies to post #172 on Portola Phramaceuticals (PTLA)

[H2R]

I agree ACTcrazy.

They have had a really good run, and given they had a positive nod and that it would be the first and only "specific reversal agent available in Europe to address life-threatening bleeding associated with the use of apixaban or rivaroxaban", I expect a CHMP approval.

Best of luck with your investments!